Association between self‐reported environmental tobacco smoke exposure and lung cancer: Modification by GSTP1 polymorphism

Environmental Tobacco Smoke (ETS) exposure has been associated with lung cancer risk. ETS is composed of emissions from cigarette smoke and contains a higher concentration of tobacco smoke carcinogens than mainstream smoke. Polymorphisms in genes that metabolize tobacco smoke carcinogens have been studied as effect modifiers of the association between active smoking and lung cancer risk. GSTP1 is a polymorphic gene that encodes for GST π, a detoxification enzyme and has a high expression in the lung. We investigated the association between ETS and lung cancer risk and the modification of this association by the GSTP1 polymorphism. Using a case‐control design, individuals were genotyped for GSTP1 using PCR‐RFLP techniques. All analyses were carried out using multiple logistic regression. The association between ETS exposure and lung cancer risk was evaluated in different strata based on smoking habits to evaluate the consistency of results. The effect of the GSTP1 polymorphisms on lung cancer risk was evaluated by considering the joint effect of having both an ETS exposure and the GSTP1 GG genotype compared to the absence of ETS exposure and the GSTP1 AA genotype as a reference group as well as doing stratified analysis by genotype. ETS exposure was associated consistently with higher lung cancer risk in all the strata considered. The adjusted odds ratios (AOR) evaluating the association between ETS and lung cancer risk for the different strata were: nonsmokers (Cases/Controls 66/413; AOR = 1.38; 95% CI = 0.78–2.43), ex‐smokers (Cases/Controls 560/527; AOR = 1.66; 95% CI = 1.22–2.25), current smokers (Cases/Controls 415/219; AOR = 1.56; 95% CI = 1.00–2.41). The AORs for ex‐smokers and light smoking subgroups were: ex‐smokers who quit for 19 years or more (Cases/Controls 144/244; AOR = 2.64; 95% CI = 1.55–4.50), ex‐smokers who quit for 10–19 years (Cases/Controls 141/128; AOR = 1.16; 95% CI = 0.66–2.04), ex‐smokers who quit for 10 years or less (Cases/Controls 247/122; AOR = 1.45; 95% CI = 0.83–2.55) and participants who had <15 packyears and nonsmokers combined (Cases/Controls 143/640; AOR = 1.52; 95% CI = 1.02–2.28). Among those with the GSTP1 GG genotype the ETS‐lung cancer risk association was greater than those with the GSTP1 AA genotype: nonsmokers (GSTP1 GG AOR = 7.84; 95% CI = 0.80–76.68; GSTP1 AA AOR = 1.15; 95% CI = 0.46–2.90), ex‐smokers (GSTP1 GG AOR = 2.32; 95% CI = 0.90–5.96; GSTP1 AA AOR = 2.15; 95% CI = 1.34–3.44),, current smokers (GSTP1 GG AOR = 1.75; 95% CI = 0.42–7.32; GSTP1 AA AOR = 1.32; 95% CI = 0.67–2.58) and participants who had <15 packyears and nonsmokers (GSTP1 GG AOR = 1.93; 95% CI = 0.54–6.97; GSTP1 AA AOR = 1.58; 95% CI = 0.83–3.01). We found that ETS exposure is associated with higher lung cancer risk. Furthermore, the presence of the GSTP1 GG genotype appears to enhance the magnitude of the association between ETS exposure and lung cancer. Larger studies will be needed to confirm these preliminary findings. © 2003 Wiley‐Liss, Inc.

[1]  G. Pershagen,et al.  A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls , 1998, Cancer Causes & Control.

[2]  Xiping Xu,et al.  A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States) , 1997, Cancer Causes & Control.

[3]  D. Dockery,et al.  Risk of lung cancer from environmental exposures to tobacco smoke , 1997, Cancer Causes & Control.

[4]  W. Ahrens,et al.  Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  G. Pershagen,et al.  p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. , 2000, Cancer research.

[6]  D. Phillips,et al.  Polymorphisms of the GSTP1 and GSTM1 genes and PAH‐DNA adducts in human mononuclear white blood cells , 2000, Environmental and molecular mutagenesis.

[7]  E. Bowman,et al.  Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. , 1999, Journal of the National Cancer Institute.

[8]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[9]  D. Warburton,et al.  Molecular and genetic damage from environmental tobacco smoke in young children. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  S. Hammond,et al.  Exposure of U.S. workers to environmental tobacco smoke. , 1999, Environmental health perspectives.

[11]  J H Lubin,et al.  Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. , 1999, American journal of epidemiology.

[12]  K. Noda,et al.  Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. , 1999, Cancer letters.

[13]  G. Swanson,et al.  Increased cancer risk among relatives of nonsmoking lung cancer cases , 1999, Genetic epidemiology.

[14]  S. Mayne,et al.  Previous lung disease and risk of lung cancer among men and women nonsmokers. , 1999, American journal of epidemiology.

[15]  P. Dayer,et al.  Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. , 1998, Pharmacogenetics.

[16]  W. Ahrens,et al.  Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. , 1998, Journal of the National Cancer Institute.

[17]  K. Hemminki,et al.  Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  A. Townsend,et al.  Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells. , 1998, Molecular pharmacology.

[19]  S. R. Wilson,et al.  Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. , 1998, Pharmacogenetics.

[20]  G. B. Smith,et al.  Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. , 1998, Carcinogenesis.

[21]  N J Wald,et al.  The accumulated evidence on lung cancer and environmental tobacco smoke , 1997, BMJ.

[22]  D. Spiegelman,et al.  Power and sample size calculations for case-control studies of gene-environment interactions with a polytomous exposure variable. , 1997, American journal of epidemiology.

[23]  L. Harries,et al.  Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. , 1997, Carcinogenesis.

[24]  John A. Pickrell,et al.  Casarett and Doull's toxicology: The basic science of poisons , 1996 .

[25]  J. Ockene,et al.  Occupational exposure to environmental tobacco smoke. , 1996, JAMA.

[26]  D. Christiani,et al.  Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  S. Anttila,et al.  Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. , 1995, Carcinogenesis.

[28]  Curtis D. Klaassen,et al.  Casarett and Doull's Toxicology. The Basic Science of Poisons , 1981 .

[29]  B. Ferris,et al.  Epidemiology Standardization Project (American Thoracic Society). , 1978, The American review of respiratory disease.